Deadline: August 15, 2025
Applications are now open for the Co-Innovation Programme, inviting Singaporean start-ups to apply for collaborative projects with Charité and BIH.
As part of its strategic internationalisation efforts, Charité – Universitätsmedizin Berlin, the Berlin Institute of Health (BIH) and Enterprise Singapore (ESG) have jointly launched a Co-Innovation Programme. With the signing of a Memorandum of Understanding (MoU) in November 2023, the foundation was laid for a professional network connecting innovative start-ups from Singapore with leading scientists at Charité and BIH. The goal is to jointly develop new research and translational projects in the fields of biomedicine and health technology – from early-stage research to clinical trials and market readiness. Team Match & Connect of Charité BIH Innovation coordinates the program.
Funding Tracks
- Two funding tracks are available:
- Pilot or Validation Studies
- For solutions that are clinically ready or near-ready for pilot evaluation (e.g., post design freeze or with recent regulatory approval).
- Joint Product Development
- For innovative technologies co-developed with Charité/BIH, including prototyping, MVPs, or joint IP projects.
- Pilot or Validation Studies
Funding Information
- Project funding is split equally – 50% covered by Enterprise Singapore and 50% by the participating start-ups.
For more information, visit BIH.
